glp 1 liver toxicity Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty disease: could the combinations of an old friend with new players yield better outcomes? GLP-1 Receptor Agonists for Non-Alcoholic

We welcome recommendations and comments about our customer service, delivery, packaging or how much we care for you, naturally :-) Thank you for your feedback!

In this mouse model of colorectal cancer, NRF2 was activated by pterostilbene or resveratrol

Routine rechecking of serum B12 levels is not generally recommended for patients on regular injections as levels will be artificially high

Due to the generally low intake of B12, supplement dosages must be significantly higher thus the daily requirement is covered only with supplements of approx

AASLD Applauds FDA Approval of First GLP-1 Therapy for MASH, Expanding Use of Popular Weight Loss Drug to Liver Disease

Keeping a simple injection diary or using a smartphone app can help patients track their rotation pattern, particularly important for those using multiple injectable medications